Treatment of cancer with immune stimulators
AssigneeSciclone Pharmaceuticals International (Sg) Pte. Ltd.
InventorsRobert S. KING, Cynthia W. TUTHILL, Friedhelm BLOBEL
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
Claims22
A method for determining the responsiveness of a human subject to cancer treatment comprising determining the level of activity of one or more biomarkers in a biological sample from a human subject, wherein the biomarkers are selected from the group consisting of IL-1β, IL-4, IL-6, and IL-10.
A method of treating cancer in a subject comprising administering a therapeutically effective amount of an alpha thymosin peptide and a therapeutically effective amount of an immune stimulator.
Dependencies are inferred from the claim text.